SynergyMed Cancer Treatment
SynergyMed is a pioneering startup focused on revolutionizing cancer treatment through its non-invasive technology that allows tumors to vanish within days. Their innovative approach combines electromagnetic energy with FDA-approved nanoparticles, targeting tumors precisely while minimizing damage to surrounding healthy tissue. With signed letters of intent from major companies like Boston Scientific and Medtronic, SynergyMed is poised for significant growth in the biotech sector.
In their current crowdfunding round, SynergyMed is raising $352,306 from investors, with a valuation cap set at $16 million. The minimum investment required to participate is $100, allowing a broad range of investors to support this groundbreaking technology.
- Crowd Funding Link
- https://wefunder.com/synergymed
- Website Link
- https://www.synergymed-ltd.com/
- SEC Filing Link
- https://www.sec.gov/Archives/edgar/data/1811959/000167025424001055/xslC_X01/primary_doc.xml
- Additional Links
π¨βπΌ
This report evaluates key performance areas with detailed insights.
- β
Clear Title Presentation
- βConcise Explanation
π
This report evaluates key performance areas with detailed insights.
- β
Evidence of Market Validation
- βNumber of Paying Users or Customers
- βRevenue Generated So Far
- βGrowth Rate of Users, Customers, and Revenue
- β
Partnerships and Collaborations
π
This report evaluates key performance areas with detailed insights.
- β
Total Addressable Market (TAM) Evaluation
- β
Serviceable Available Market (SAM) Evaluation
- β
Serviceable Obtainable Market (SOM) and Unique Value Proposition
- β
Competition and Market Positioning
- βProfit Margins and Financial Performance
β±οΈ
This report evaluates SynergyMed's performance in key areas with detailed insights.
- β
Evidence of Market Validation
- βAmount of Real Paid Orders or Customers
- β
Number of Iterations and Product Progress
- βSpeed of Growth
- βComparison to Industry Incumbents
π°
This report evaluates SynergyMed's valuation using industry benchmarks and startup metrics.
- β
Valuation Based on Industry and Market Size
- β
Valuation Based on Traction and Progress
- βValuation Based on Past Sales
- β
Valuation Based on Future Revenue Projections
- βValuation Based on Profit Margins and Future Profits
π
This report evaluates key performance areas with detailed insights.
- βYearly Revenue and Growth Rate
- βBurn Rate and Runway
- βFund Utilization Efficiency
- βClarity of New Funds Allocation
- βRunway of the Startup